327 filings
Page 8 of 17
EFFECT
NVNO
enVVeno Medical Corporation
23 Oct 20
Notice of effectiveness
12:15am
4
NVNO
enVVeno Medical Corporation
21 Oct 20
Hancock Jaffe Laboratories / Matthew Jenusaitis ownership change
4:05pm
3
NVNO
enVVeno Medical Corporation
21 Oct 20
Hancock Jaffe Laboratories / Matthew Jenusaitis ownership change
4:05pm
CORRESP
NVNO
enVVeno Medical Corporation
20 Oct 20
Correspondence with SEC
12:00am
SC 13G
NVNO
enVVeno Medical Corporation
15 Oct 20
Hancock Jaffe Laboratories / Empery Asset Management ownership change
10:53am
424B5
NVNO
enVVeno Medical Corporation
8 Oct 20
Prospectus supplement for primary offering
5:26pm
8-K
NVNO
enVVeno Medical Corporation
8 Oct 20
Entry into a Material Definitive Agreement
5:25pm
4
NVNO
enVVeno Medical Corporation
1 Oct 20
Change in insider ownership
9:25pm
UPLOAD
NVNO
enVVeno Medical Corporation
24 Sep 20
Letter from SEC
12:00am
S-3
NVNO
enVVeno Medical Corporation
Shelf registration
17 Sep 20
4:05pm
8-K
NVNO
enVVeno Medical Corporation
16 Sep 20
Amendments to Articles of Incorporation or Bylaws
5:27pm
DEFA14A
NVNO
enVVeno Medical Corporation
19 Aug 20
Additional proxy soliciting materials
12:00am
10-Q
2020 Q2
NVNO
enVVeno Medical Corporation
Quarterly report
14 Aug 20
12:00am
UPLOAD
NVNO
enVVeno Medical Corporation
13 Aug 20
Letter from SEC
12:00am
DEF 14A
NVNO
enVVeno Medical Corporation
Definitive proxy
12 Aug 20
4:00pm
CORRESP
NVNO
enVVeno Medical Corporation
10 Aug 20
Correspondence with SEC
12:00am
UPLOAD
NVNO
enVVeno Medical Corporation
10 Aug 20
Letter from SEC
12:00am
144
Zhivilo Yury
7 Aug 20
Notice of proposed sale of securities
1:43pm
D
NVNO
enVVeno Medical Corporation
4 Aug 20
$1.56M in equity / options / securities to be acquired, sold $1.56M, 4 investors
4:08pm